kigelia africana leaf extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identified for kigelia africana leaf extract. Peer‑reviewed literature reports pharmacological and topical activities (antioxidant, antimicrobial, anti‑inflammatory) but no animal or human reproductive toxicity or teratogenicity data were found, therefore no evidence of reproductive hazard; topical use would be expected to give low but measurable dermal exposure in adults (low systemic absorption typical for botanical extracts) (sources: PubMed, PubChem, ECHA C&L, CosIng).
Related ingredients
Frequently asked questions
- kigelia africana leaf extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identified for kigelia africana leaf extract. Peer‑reviewed literature reports pharmacological and topical activities (antioxidant, antimicrobial, anti‑inflammatory) but no animal or human reproductive toxicity or teratogenicity data were found, therefore no evidence of reproductive hazard; topical use would be expected to give low but measurable dermal exposure in adults (low systemic absorption typical for botanical extracts) (sources: PubMed, PubChem, ECHA C&L, CosIng).
- kigelia africana leaf extract est-il sûr pendant l'allaitement ?
- No data indicating reproductive or lactation toxicity or breastmilk transfer. In absence of evidence for systemic reproductive toxicity, hazard and mechanism are scored 0; low but measurable systemic exposure from topical use is plausible, so exposure scored as low (adult topical exposure) (sources: PubMed, PubChem, ECHA C&L, CosIng).
- kigelia africana leaf extract est-il sûr pour la peau de bébé ?
- No infant‑specific safety or developmental toxicity data were identified. Hazard and mechanism remain 0 due to lack of evidence for reproductive/endocrine effects. Exposure for baby skin is increased relative to adults because of thinner/immature barrier and higher surface‑area‑to‑weight; therefore exposure is elevated to moderate for 0–3 yr (adult low exposure +1) (sources: PubMed, PubChem, CosIng, ECHA C&L).
- Comment VeriMom évalue-t-il kigelia africana leaf extract ?
- VeriMom évalue kigelia africana leaf extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à kigelia africana leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à kigelia africana leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.